Trial · NCT01919164
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Placebo | 108 | |
| Overall Study | STARTED | Sprifermin (AS902330) 30 mcg/Placebo - 2 Cycles | 110 | |
| Overall Study | STARTED | Sprifermin (AS902330) 30 mcg- 4 Cycles | 111 | |
| Overall Study | STARTED | Sprifermin (AS902330) 100 mcg/Placebo (2 Cycles) | 110 | |
| Overall Study | STARTED | Sprifermin (AS902330) 100 mcg- 4 Cycles | 110 | |
| Overall Study | Safety Analysis Set | Placebo | 107 | |
| Overall Study | Safety Analysis Set | Sprifermin (AS902330) 30 mcg/Placebo - 2 Cycles | 109 | |
| Overall Study | Safety Analysis Set | Sprifermin (AS902330) 30 mcg- 4 Cycles | 111 | |
| Overall Study | Safety Analysis Set | Sprifermin (AS902330) 100 mcg/Placebo (2 Cycles) | 111 | |
| Overall Study | Safety Analysis Set | Sprifermin (AS902330) 100 mcg- 4 Cycles | 109 | |
| Overall Study | COMPLETED | Placebo | 65 | |
| Overall Study | COMPLETED | Sprifermin (AS902330) 30 mcg/Placebo - 2 Cycles | 80 | |
| Overall Study | COMPLETED | Sprifermin (AS902330) 30 mcg- 4 Cycles | 74 | |
| Overall Study | COMPLETED | Sprifermin (AS902330) 100 mcg/Placebo (2 Cycles) | 82 | |
| Overall Study | COMPLETED | Sprifermin (AS902330) 100 mcg- 4 Cycles | 77 | |
| Overall Study | NOT COMPLETED | Placebo | 43 | |
| Overall Study | NOT COMPLETED | Sprifermin (AS902330) 30 mcg/Placebo - 2 Cycles | 30 | |
| Overall Study | NOT COMPLETED | Sprifermin (AS902330) 30 mcg- 4 Cycles | 37 | |
| Overall Study | NOT COMPLETED | Sprifermin (AS902330) 100 mcg/Placebo (2 Cycles) | 28 | |
| Overall Study | NOT COMPLETED | Sprifermin (AS902330) 100 mcg- 4 Cycles | 33 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01919164/flow